In gastric cancer, myricetin can bind to RSK2, resulting in an increased expression of Mad1, and enhancement of the inhibition of HGC-27 and SGC7901 cells’ proliferation (Feng et al., 2015). This evidence concerns the gene RPS6KA3 and gastric cancer.